Kardigan, Inc. (KARD)
Latest KARD Insider Trades
About Kardigan, Inc. (KARD)
Kardigan Inc is a clinical-stage therapeutics company focused on developing medicines for cardiovascular diseases. Its activities include the research and development of targeted therapies for cardiovascular conditions for which no approved treatments currently exist. The company's clinical-stage programs include Danicamtiv, Ataciguat, and Tonlamarsen, which are being developed for cardiovascular disease indications. The company operates and manages its business as a single operating and reportable segment, focused on the discovery and development of novel therapeutic products to treat cardiovascular disease.
- SOUTH SAN FRANCISCO, CA
- 2026
- XNAS
90-Day SEC Filing Activity
| Form 4 transaction type | Transactions | Shares | Total value |
|---|---|---|---|
| Open-market purchase | 3 | 5,625,000 | $90.00M |
| Grant or award | 11 | 436,657 | |
| Other acquisition / disposition | 24 | 68,437,171 |
KARD Insider Transactions (Form 4)
3816 Form 4 filings on record, the earliest from Jun 22, 2026, newest first.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| PERCEPTIVE ADVISORS LLC | Grant or award | Common Stock | 20,706 | $0.00 |
Recent KARD Form 8-K Filings
2KARD Insider Trading - FAQ
What is the latest insider trade for KARD?
Kardigan, Inc. (KARD) had 16 insider filings in the last 90 days, with the most recent on 2026-07-13. The full record for KARD runs to 16 Form 4 filings, the earliest from 2026-06-22. InsiderAlpha tracks every Form 4, Form 144, and 8-K filing in real time.
How many insiders are buying KARD stock?
3 insider purchases of KARD were filed in the last 90 days, totaling $90.00M.
How many insiders are selling KARD stock?
No insider sales of KARD were filed in the last 90 days.
Where can I see KARD SEC filings (Form 4, 10-K, 10-Q, 8-K)?
This page tracks KARD Form 4 insider transactions, Form 144 sale notices, and 8-K material event disclosures in one timeline. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
How can I follow KARD insider buys?
Create a free InsiderAlpha account and press Watch on this page to add KARD to your watchlist. A free account also opens the full scored daily plan with every past day and 3 months of price history. No card is required. Sign up at https://insideralpha.ai/register.
More Companies with Insider Activity
Recent Insider Filings
10Every Form 4 below links to the original document on SEC EDGAR, so the numbers on this page can be checked against the filing they came from.
- - PERCEPTIVE ADVISORS LLC view on EDGAR
- - HRTG GPE, LLC view on EDGAR
- - Paul L. Berns view on EDGAR
- - ARCH Venture Partners XIII, LLC view on EDGAR
- - HRTG GPE, LLC view on EDGAR
- - ARCH Venture Partners XIII, LLC view on EDGAR
- - Andy Pasternak view on EDGAR
- - David P. Meeker view on EDGAR
- - Paul L. Berns view on EDGAR
Learn More
- What is SEC Form 4?
- The filing insiders must submit within two business days of a trade, and how to read its transaction codes.
- Insider activity by sector
- Where buying and selling is concentrated across the eleven GICS sectors.
- Every recent Form 4
- The full market-wide feed, updated as filings arrive from SEC EDGAR.
Track KARD insider activity as it files
Real-time Form 4 alerts, AI-scored daily trade ideas and 10b5-1 plan flags.
